查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1695028

2025年全球智慧藥物傳輸系統市場報告

Smart Drug Delivery Systems Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年智慧藥物輸送系統市場規模將快速成長。到 2029 年，這一數字將成長至 310.1 億美元，複合年成長率為 19.6%。預測期內的成長可歸因於非傳染性疾病負擔的增加、對精準醫療的日益關注、預後診斷的增加、對非侵入性藥物輸送方法的需求的增加以及醫療保健支出的增加。預測期內的關鍵趨勢包括小型化和微製造技術、材料科學的進步、人工智慧 (AI) 和機器學習 (ML) 的融合、奈米級藥物傳輸系統的開發以及物聯網和穿戴式技術的融合。

慢性病盛行率的不斷上升預計將推動智慧藥物輸送系統市場的擴張。慢性病是長期健康狀況，逐漸發展，通常由多種因素引起。這些疾病的盛行率不斷上升，受到人口老化、環境因素和醫療保健機會不平等的影響。智慧藥物輸送系統透過提高藥物療效和增加患者依從性，為管理慢性疾病提供了一個有希望的解決方案。例如，根據美國醫學圖書館－國家醫學圖書館2023年1月發布的報告，預計到2050年，美國患有至少一種慢性病的人數將達到1.4266億，比2020年的7152.2萬人成長99.5%。因此，慢性病盛行率的上升正在推動智慧藥物輸送系統市場的成長。

智慧藥物輸送系統市場的關鍵參與者正致力於開發能夠徹底改變藥物管理的創新可重複使用藥物輸送設備。其中之一就是 Qfinity，一種可重複使用的藥物傳輸裝置，專為皮下自我給藥而設計。與一次性使用不同，Qfinity 可用於多次注射，從而減少廢棄物並提供環境效益。例如，捷普公司 (Jabil Inc.) 於 2022 年 5 月推出了 Qfinity。該設備每台可注射超過 100 次，並與各種預填充藥筒相容。該設備不僅可以減少每次注射的碳排放，而且功能多樣，可適應各種藥物的體積和黏度。此外，連網版本 Qfinity+ 可透過內建感測器和電子設備遠端監控患者照護和依從性，確保連接性且不影響易用性。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球智慧型藥物傳輸系統PESTEL分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
  • 最終用途產業分析
  • 全球智慧藥物輸送系統市場：成長率分析
  • 全球智慧藥物傳輸系統市場表現：規模與成長，2019-2024
  • 全球智慧藥物傳輸系統市場預測：規模與成長，2024-2029 年，2034 年
  • 全球智慧型藥物傳輸系統總目標市場（TAM）

第6章市場區隔

  • 全球智慧藥物傳輸系統市場（按產品、性能和預測）2019-2024 年、2024-2029 年、2034 年
  • 連接吸入器
  • 已連接的自動注射器
  • 可連接筆式注射器
  • 連網穿戴注射器
  • 附加元件感測器
  • 其他產品
  • 全球智慧型藥物傳輸系統市場（依治療領域、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 代謝紊亂
  • 神經系統疾病
  • 呼吸系統疾病
  • 荷爾蒙失調
  • 其他治療領域
  • 全球智慧藥物傳輸系統市場（按藥物傳輸模式、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 注射劑
  • 吸入
  • 口服
  • 全球智慧型藥物傳輸系統市場（依最終用戶、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 居家護理
  • 門診治療環境
  • 其他最終用戶
  • 全球智慧藥物傳輸系統市場，按聯網吸入器類型細分，性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 乾粉吸入器（DPI）
  • 定量噴霧吸入器（MDI）
  • 全球智慧型藥物傳輸系統市場、連網自動注射器細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 單劑量自動注射器
  • 多劑量自動注射器
  • 全球智慧藥物傳輸系統市場，依連網筆式注射器類型細分，效能及預測，2019-2024 年、2024-2029 年、2034 年
  • 胰島素筆注射器
  • 生物製藥筆式注射器
  • 全球智慧藥物傳輸系統市場、連網和穿戴式注射器細分（按類型、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 穿戴式胰島素注射器
  • 輸液幫浦 穿戴式注射器
  • 全球智慧型藥物傳輸系統市場、附加附加元件細分、類型、效能及預測（2019-2024 年、2024-2029 年、2034 年）
  • 血糖值監測感測器
  • 藥物依從性感測器
  • 溫度感測器
  • 全球智慧藥物傳輸系統市場、其他產品細分、按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 智慧注射器
  • 智慧型貼片
  • 智慧植入

第7章 區域和國家分析

  • 全球智慧型藥物傳輸系統市場（按地區、績效及預測）：2019-2024 年、2024-2029 年、2034 年
  • 全球智慧型藥物傳輸系統市場（依國家/地區分類）、績效及預測（2019-2024 年、2024-2029 年、2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 智慧藥物輸送系統市場：競爭格局
  • 智慧藥物輸送系統市場：公司簡介
    • Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Medtronic plc
  • Eli Lilly and Company
  • Amgen Inc
  • Novo Nordisk
  • Merck Group
  • Becton Dickinson and Company
  • Stryker Corporation
  • Baxter International Inc
  • Boston Scientific Corporation
  • Biogen Inc
  • Vertex Pharmaceuticals Incorporated
  • Phillips-Medisize Corporation
  • ResMed Inc
  • West Pharmaceutical Services Inc
  • Insulet Corporation

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年智慧藥物輸送系統市場：提供新機會的國家
  • 2029年智慧藥物輸送系統市場：細分市場將帶來新機會
  • 2029年智慧藥物傳輸系統市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r29006

Smart drug delivery systems encompass advanced technologies aimed at enhancing the efficacy, safety, and targeted delivery of pharmaceutical compounds within the body. These systems utilize diverse approaches to regulate drug release, improve bioavailability, and minimize adverse effects.

The primary products within smart drug delivery systems include connected inhalers, connected autoinjectors, connected pen injectors, connected wearable injectors, add-on sensors, and other related devices. Connected inhalers, for instance, are electronic monitoring systems integrated into inhalers, which track drug usage and may provide feedback on device technique. These systems find applications across various therapeutic areas such as metabolic disorders, neurological disorders, respiratory disorders, hormonal disorders, and more. They can deliver drugs via different modes including injectable, inhalation, and oral routes, and cater to a range of end users including hospitals, clinics, home care settings, ambulatory care facilities, among others.

The smart drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides smart drug delivery systems market statistics, including smart drug delivery systems industry global market size, regional shares, competitors with smart drug delivery systems market share, detailed smart drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the smart drug delivery systems industry. This smart drug delivery systems market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The smart drug delivery systems market size has grown rapidly in recent years. It will grow from $12.65 billion in 2024 to $15.17 billion in 2025 at a compound annual growth rate (CAGR) of 19.9%. The growth in the historic period can be attributed to increasing demand for drug delivery systems, rising patient compliance, rising prevalence of chronic diseases, increasing personalized medicine, and need for cost-effective healthcare solutions.

The smart drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $31.01 billion in 2029 at a compound annual growth rate (CAGR) of 19.6%. The growth in the forecast period can be attributed to growing burden of non-communicable diseases, increased focus on precision medicine, the rise of theragnostic, growing demand for non-invasive drug delivery methods, and increasing healthcare expenditure. Major trends in the forecast period include miniaturization and microfabrication technologies, advancements in material science, integration of artificial intelligence (AI) and machine learning (ML), development of nano-sized drug delivery systems, and integration of IoT and wearable technology.

The growing prevalence of chronic diseases is expected to drive the expansion of the smart drug delivery systems market. Chronic diseases are long-term health conditions that develop gradually and are often caused by a combination of factors. The increasing prevalence of these diseases is influenced by aging populations, environmental factors, and disparities in healthcare access. Smart drug delivery systems present a promising solution for managing chronic diseases by improving medication effectiveness and enhancing patient adherence. For example, a January 2023 report from the National Library of Medicine, a US-based medical library, projects that by 2050, 142.66 million people in the United States will have at least one chronic illness, representing a 99.5% increase from 71.522 million in 2020. As a result, the rising prevalence of chronic diseases is driving growth in the smart drug delivery systems market.

Key players in the smart drug delivery systems market are focused on developing innovative reusable drug delivery devices to revolutionize drug administration. One such device is Qfinity, a reusable drug delivery device designed for subcutaneous self-administration of medication. Unlike single-use devices, Qfinity can be utilized for multiple injections, reducing waste and offering environmental benefits. For instance, Jabil Inc. launched Qfinity in May 2022, featuring the capability to handle over 100 injections per device and accommodating various pre-filled cartridges. The device not only reduces the carbon footprint per injection but also offers versatility in handling different drug volumes and viscosities. Additionally, the connected version, Qfinity+, enables remote monitoring of patient care and compliance through built-in sensors and electronics, ensuring connectivity without compromising ease of use.

In October 2023, Novo Nordisk A/S strengthened its position in the smart drug delivery systems market through the acquisition of Biocorp Production SA for $164.5 million. This strategic move aims to augment Novo Nordisk's capabilities in developing innovative connected devices and delivery solutions, exemplified by Mallya, a smart add-on device for pen injectors. Biocorp, a France-based designer and manufacturer of medical devices and drug delivery systems, brings expertise in connected devices that align with Novo Nordisk's focus on advancing drug delivery technologies to enhance patient care and treatment outcomes.

Major companies operating in the smart drug delivery systems market are Pfizer Inc., Johnson & Johnson, Bayer AG, Abbott Laboratories, Novartis International AG, Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk, Merck Group, Becton Dickinson and Company, Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, Biogen Inc., Vertex Pharmaceuticals Incorporated, Phillips-Medisize Corporation, ResMed Inc., West Pharmaceutical Services Inc., Insulet Corporation, Owen Mumford Ltd., Sonceboz, H&T Presspart Manufacturing Ltd., E3D Elcam Drug Delivery Devices, CeQur Corporation

North America was the largest region in the smart drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the smart drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smart drug delivery systems market consists of revenues earned by entities by providing services such as personalized drug delivery, targeted treatment, diagnostic integration, remote monitoring, and feedback mechanisms. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart drug delivery systems market also includes sales of products including microfluidic devices, transdermal drug delivery patches, electroceutical devices, and remote-controlled drug delivery devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smart Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on smart drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The smart drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Connected Inhalers; Connected Autoinjectors; Connected Pen Injectors; Connected Wearable Injectors; Add-On Sensors; Other Products
  • 2) By Therapeutic Area: Metabolic Disorders; Neurological Disorders; Respiratory Disorders; Hormonal Disorders; Other Therapeutic Areas
  • 3) By Drug Delivery Mode: Injectable; Inhalation; Oral
  • 4) By End-User: Hospitals; Clinics; Home Care; Ambulatory Care Settings; Other End-Users
  • Subsegments:
  • 1) By Connected Inhalers: Dry Powder Inhalers (DPIs); Metered Dose Inhalers (MDIs)
  • 2) By Connected Autoinjectors: Single-Dose Autoinjectors; Multi-Dose Autoinjectors
  • 3) By Connected Pen Injectors: Insulin Pen Injectors; Biologic Pen Injectors
  • 4) By Connected Wearable Injectors: Insulin Wearable Injectors; Infusion Pump Wearable Injectors
  • 5) By Add-On Sensors: Glucose Monitoring Sensors; Medication Adherence Sensors; Temperature Sensors
  • 6) By Other Products: Smart Syringes; Smart Patches; Smart Implants
  • Companies Mentioned: Pfizer Inc; Johnson & Johnson; Bayer AG; Abbott Laboratories; Novartis International AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Smart Drug Delivery Systems Market Characteristics

3. Smart Drug Delivery Systems Market Trends And Strategies

4. Smart Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Smart Drug Delivery Systems Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Smart Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Smart Drug Delivery Systems Market Growth Rate Analysis
  • 5.4. Global Smart Drug Delivery Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Smart Drug Delivery Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Smart Drug Delivery Systems Total Addressable Market (TAM)

6. Smart Drug Delivery Systems Market Segmentation

  • 6.1. Global Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Connected Inhalers
  • Connected Autoinjectors
  • Connected Pen Injectors
  • Connected Wearable Injectors
  • Add-On Sensors
  • Other Products
  • 6.2. Global Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metabolic Disorders
  • Neurological Disorders
  • Respiratory Disorders
  • Hormonal Disorders
  • Other Therapeutic Areas
  • 6.3. Global Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Injectable
  • Inhalation
  • Oral
  • 6.4. Global Smart Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Home Care
  • Ambulatory Care Settings
  • Other End-Users
  • 6.5. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Connected Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dry Powder Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
  • 6.6. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Connected Autoinjectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Dose Autoinjectors
  • Multi-Dose Autoinjectors
  • 6.7. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Connected Pen Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insulin Pen Injectors
  • Biologic Pen Injectors
  • 6.8. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Connected Wearable Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insulin Wearable Injectors
  • Infusion Pump Wearable Injectors
  • 6.9. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Add-On Sensors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Glucose Monitoring Sensors
  • Medication Adherence Sensors
  • Temperature Sensors
  • 6.10. Global Smart Drug Delivery Systems Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Smart Syringes
  • Smart Patches
  • Smart Implants

7. Smart Drug Delivery Systems Market Regional And Country Analysis

  • 7.1. Global Smart Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Smart Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Smart Drug Delivery Systems Market

  • 8.1. Asia-Pacific Smart Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Smart Drug Delivery Systems Market

  • 9.1. China Smart Drug Delivery Systems Market Overview
  • 9.2. China Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Smart Drug Delivery Systems Market

  • 10.1. India Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Smart Drug Delivery Systems Market

  • 11.1. Japan Smart Drug Delivery Systems Market Overview
  • 11.2. Japan Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Smart Drug Delivery Systems Market

  • 12.1. Australia Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Smart Drug Delivery Systems Market

  • 13.1. Indonesia Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Smart Drug Delivery Systems Market

  • 14.1. South Korea Smart Drug Delivery Systems Market Overview
  • 14.2. South Korea Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Smart Drug Delivery Systems Market

  • 15.1. Western Europe Smart Drug Delivery Systems Market Overview
  • 15.2. Western Europe Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Smart Drug Delivery Systems Market

  • 16.1. UK Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Smart Drug Delivery Systems Market

  • 17.1. Germany Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Smart Drug Delivery Systems Market

  • 18.1. France Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Smart Drug Delivery Systems Market

  • 19.1. Italy Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Smart Drug Delivery Systems Market

  • 20.1. Spain Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Smart Drug Delivery Systems Market

  • 21.1. Eastern Europe Smart Drug Delivery Systems Market Overview
  • 21.2. Eastern Europe Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Smart Drug Delivery Systems Market

  • 22.1. Russia Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Smart Drug Delivery Systems Market

  • 23.1. North America Smart Drug Delivery Systems Market Overview
  • 23.2. North America Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Smart Drug Delivery Systems Market

  • 24.1. USA Smart Drug Delivery Systems Market Overview
  • 24.2. USA Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Smart Drug Delivery Systems Market

  • 25.1. Canada Smart Drug Delivery Systems Market Overview
  • 25.2. Canada Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Smart Drug Delivery Systems Market

  • 26.1. South America Smart Drug Delivery Systems Market Overview
  • 26.2. South America Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Smart Drug Delivery Systems Market

  • 27.1. Brazil Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Smart Drug Delivery Systems Market

  • 28.1. Middle East Smart Drug Delivery Systems Market Overview
  • 28.2. Middle East Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Smart Drug Delivery Systems Market

  • 29.1. Africa Smart Drug Delivery Systems Market Overview
  • 29.2. Africa Smart Drug Delivery Systems Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Smart Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Smart Drug Delivery Systems Market, Segmentation By Drug Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Smart Drug Delivery Systems Market Competitive Landscape And Company Profiles

  • 30.1. Smart Drug Delivery Systems Market Competitive Landscape
  • 30.2. Smart Drug Delivery Systems Market Company Profiles
    • 30.2.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

31. Smart Drug Delivery Systems Market Other Major And Innovative Companies

  • 31.1. Medtronic plc
  • 31.2. Eli Lilly and Company
  • 31.3. Amgen Inc
  • 31.4. Novo Nordisk
  • 31.5. Merck Group
  • 31.6. Becton Dickinson and Company
  • 31.7. Stryker Corporation
  • 31.8. Baxter International Inc
  • 31.9. Boston Scientific Corporation
  • 31.10. Biogen Inc
  • 31.11. Vertex Pharmaceuticals Incorporated
  • 31.12. Phillips-Medisize Corporation
  • 31.13. ResMed Inc
  • 31.14. West Pharmaceutical Services Inc
  • 31.15. Insulet Corporation

32. Global Smart Drug Delivery Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Smart Drug Delivery Systems Market

34. Recent Developments In The Smart Drug Delivery Systems Market

35. Smart Drug Delivery Systems Market High Potential Countries, Segments and Strategies

  • 35.1 Smart Drug Delivery Systems Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Smart Drug Delivery Systems Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Smart Drug Delivery Systems Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer